10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10
** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.

Hybrid Event

2nd - 3rd July 2026 | Geneva, Switzerland

International Symposium on Oncology, Immunotherapy and Biomarkers (ISOIB - 26)

Apply to Present Register as Listener
Register for Participation → View available registration categories.
4

Days

4

Hrs

07

Min

02

Sec

Call For Paper

The (ISOIB) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Oncology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Biomarkers in cancer diagnosis and treatment
02
Immunotherapy and its clinical applications
03
Role of precision medicine in oncology
04
Emerging trends in cancer immunotherapy
05
Biomarker discovery and validation
06
Challenges in immunotherapy implementation
07
Patient selection for immunotherapy
08
Combination therapies with immunotherapy
09
Ethical issues in biomarker research
10
Impact of biomarkers on treatment outcomes
11
Innovative technologies in biomarker analysis
12
Clinical trials for immunotherapeutic agents
13
Role of the immune system in cancer
14
Biomarkers for early cancer detection
15
Patient perspectives on immunotherapy
16
Regulatory considerations for biomarker use
17
Future directions in immunotherapy research
18
Collaboration between academia and industry
19
Health disparities in access to immunotherapy
20
Integrating biomarkers into clinical practice

Peer Review Process

All submissions evaluated through structured peer-review to ensure academic rigor. Accepted papers may be considered for high-quality journals.

Registration Details

Secure your participation early. Limited slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions prioritized for publication in recognized journals and proceedings.

Submit Your Paper Today Register Early
2026 UPDATE

Consistent Academic Support

Science Net ensures that research activities continue without interruption in the current global situation. Participants can engage through digital and hybrid conference formats.